Human platelets as a platform to monitor metabolic biomarkers using stable isotopes and LC-MS

Bioanalysis

Volumn 5, Issue 24, 2013, Pages 3009-3021

  Basu, Sankha S ^a   Deutsch, Eric C ^a,b   Schmaier, Alec A ^a   Lynch, David R ^a,b   Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRYL COENZYME A; BIOLOGICAL MARKER; PALMITOYL COENZYME A HYDROLASE; PROPIONIC ACID; PROPIONYL COENZYME A; ROTENONE; SUCCINYL COENZYME A; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; THROMBOCYTE;

ACYL COENZYME A; BLOOD PLATELETS; CARBON ISOTOPES; CHROMATOGRAPHY, LIQUID; ESTERS; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; NITROGEN ISOTOPES; PROPIONATES; SULFHYDRYL COMPOUNDS;

EID: 84890419317     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.13.269     Document Type: Article

References (40)

1. Patti ME, Corvera S. The role of mitochondria in the pathogenesis of Type 2 diabetes. Endocr. Rev. 31(3), 364-395 (2010
2. Griffiths EJ. Mitochondria and heart disease. Adv. Exp. Med. Biol. 942, 249-267 (2012
3. Wallace DC. Mitochondria and cancer. Nat. Rev. Cancer 12(10), 685-698 (2012
4. Swerdlow RH. Brain aging, Alzheimer's disease, and mitochondria. Biochim. Biophys. Acta 1812(12), 1630-1639 (2011
5. Schapira AH. Targeting mitochondria for neuroprotection in Parkinson's disease. Antioxid. Redox Signal. 16(9), 965-973 (2012
6. Dhillon S, Hellings JA, Butler MG. Genetics and mitochondrial abnormalities in autism spectrum disorders: A review. Curr. Genomics 12(5), 322-332 (2011
7. Palmieri L, Persico AM. Mitochondrial dysfunction in autism spectrum disorders: Cause or effect? Biochim. Biophys. Acta 1797(6-7), 1130-1137 (2010
8. Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De MC, Butterfield DA et al. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci. 12, 1107-1123 (2007
9. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: A dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359-407 (2005
10. Sampey BP, Freemerman AJ, Zhang J et al. Metabolomic profiling reveals mitochondrial-derived lipid biomarkers that drive obesity-associated inflammation. PLoS ONE 7(6), e38812 (2012
11. Suomalainen A. Biomarkers for mitochondrial respiratory chain disorders. J. Inherit. Metab. Dis. 34(2), 277-282 (2011
12. Filiou MD, Zhang Y, Teplytska L et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol. Psychiatry 70(11), 1074-1082 (2011
13. Kristal BS, Shurubor YI, Kaddurah-Daouk R, Matson WR. Metabolomics in the study of aging and caloric restriction. Methods Mol. Biol. 371, 393-409 (2007
14. Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol. Biol. 603, 423-431 (2010
15. Spry C, Kirk K, Saliba KJ. Coenzyme A biosynthesis: An antimicrobial drug target. FEMS Microbiol. Rev. 32(1), 56-106 (2008
16. Ellis JM, Frahm JL, Li LO, Coleman RA. Acyl-coenzyme A synthetases in metabolic control. Curr. Opin. Lipidol. 21(3), 212-217 (2010
17. Haynes CA, Allegood JC, Sims K, Wang EW, Sullards MC, Merrill AH Jr. Quantitation of fatty acyl-coenzyme As in mammalian cells by liquid chromatography-electrospray ionization tandem mass spectrometry. J. Lipid Res. 49(5), 1113-1125 (2008
18. Palladino AA, Chen J, Kallish S, Stanley CA, Bennett MJ. Measurement of tissue acyl-CoAs using flow-injection tandem mass spectrometry: Acyl-CoA profiles in short-chain fatty acid oxidation defects. Mol. Genet. Metab. 107(4), 679-683 (2012
19. Magnes C, Suppan M, Pieber TR et al. Validated comprehensive analytical method for quantification of coenzyme A activated compounds in biological tissues by online solid-phase extraction LC-MS/MS. Anal. Chem. 80(15), 5736-5742 (2008
20. Ciccimaro E, Blair IA. Stable-isotope dilution LC-MS for quantitative biomarker analysis. Bioanalysis 2(2), 311-341 (2010
21. Geiger T, Wisniewski JR, Cox J et al. Use of stable isotope labeling by amino acids in cell culture as a spike-in standard in quantitative proteomics. Nat. Protoc. 6(2), 147-157 (2011
22. Basu SS, Mesaros C, Gelhaus SL, Blair IA. Stable isotope labeling by essential nutirents in cell culture for the preparation of labeled coenzyme A and its thioesters. Anal. Chem. 83(4), 1363-1369 (2011
23. Basu SS, Blair IA. SILEC: A protocol for generating and using isotopically labeled coenzyme A mass spectrometry standards. Nat. Protoc. 7(1), 1-12 (2012
24. Rangiah K, Tippornwong M, Sangar V et al. Differential secreted proteome approach in murine model for candidate biomarker discovery in colon cancer. J. Proteome Res. 8(11), 5153-5164 (2009
25. Basu SS, Blair IA. Rotenone-mediated changes in intracellular coenzyme A thioester levels: Implications for mitochondrial dysfunction. Chem. Res. Toxicol. 24(10), 1630-1632 (2011
26. Tremolizzo L, Sala G, Zoia CP, Ferrarese C. Assessing glutamatergic function and dysfunction in peripheral tissues. Curr. Med. Chem. 19(9), 1310-1315 (2012
27. Metallo CM, Walther JL, Stephanopoulos G. Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J. Biotechnol. 144(3), 167-174 (2009
28. Deutsch EC, Santani AB, Perlman SL et al. A rapid, noninvasive immunoassay for frataxin: Utility in assessment of Friedreich ataxia. Mol. Genet. Metab. 101(2-3), 238-245 (2010
29. Selak MA, Lyver E, Micklow E et al. Blood cells from Friedreich ataxia patients harbor frataxin deficiency without a loss of mitochondrial function. Mitochondrion 11(2), 342-350 (2011
30. Tanner CM, Kamel F, Ross GW et al. Rotenone, paraquat, and Parkinson's disease. Environ. Health Perspect. 119(6), 866-872 (2011
31. Metallo CM, Gameiro PA, Bell EL et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481(7381), 380-384 (2012
32. Thompson RA, Isin EM, Li Y et al. In vitro approach to assess the potential for risk of idiosyncratic adverse reactions caused by candidate drugs. Chem. Res. Toxicol. 25(8), 1616-1632 (2012
33. Rockett JC, Burczynski ME, Fornace AJ, Herrmann PC, Krawetz SA, Dix DJ. Surrogate tissue analysis: Monitoring toxicant exposure and health status of inaccessible tissues through the analysis of accessible tissues and cells. Toxicol. Appl. Pharmacol. 194(2), 189-199 (2004
34. Santos R, Lefevre S, Sliwa D, Seguin A, Camadro JM, Lesuisse E. Friedreich ataxia: Molecular mechanisms, redox considerations, and therapeutic opportunities. Antioxid. Redox Signal. 13(5), 651-690 (2010
35. Sutak R, Xu X, Whitnall M, Kashem MA, Vyoral D, Richardson DR. Proteomic analysis of hearts from frataxin knockout mice: Marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism. Proteomics 8(8), 1731-1741 (2008
36. Lynch DR, Deutsch EC, Wilson RB, Tennekoon G. Unanswered questions in Friedreich ataxia. J. Child Neurol. 27(9), 1223-1229 (2012
37. Schmucker S, Puccio H. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches. Hum. Mol. Genet. 19(R1), R103-R110 (2010
38. Mitchell GA, Gauthier N, Lesimple A, Wang SP, Mamer O, Qureshi I. Hereditary and acquired diseases of acyl-coenzyme A metabolism. Mol. Genet. Metab. 94(1), 4-15 (2008
39. Vaccaro M, Riva C, Tremolizzo L et al. Platelet glutamate uptake and release in migraine with and without aura. Cephalalgia 27(1), 35-40 (2007
40. Le A, Lane AN, Hamaker M et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15(1), 110-121 (2012